{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T09:41:23Z","timestamp":1785058883927,"version":"3.55.0"},"reference-count":39,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,4,1]]},"abstract":"<jats:p>Somatostatin (SS) and SS receptor (SSR) subtypes, code-named sst1\u20135, are heterogeneously expressed in the normal human thymus. This suggests their involvement in controlling the immune and\/or neuroendocrine functions in this organ. Moreover, recently a high in vivo uptake of[ 111In-DTPA-d-Phe1]octreotide has been reported in patients bearing thymoma. The present study characterizes in vivo and in vitro, functional SS-binding sites in a human thymoma.<\/jats:p><jats:p>A high uptake of[ 111In-DTPA-d-Phe1]octreotide was observed in the chest of a patient with myasthenia gravis due to a cortical thymoma. Specific binding of[ 125I-Tyr11]SS-14 was found on a membrane preparation of the surgically removed thymoma. Scatchard analysis showed high affinity binding sites (Kd, 47.5 \u00b1 2.5 pmol\/L) with low maximum binding capacity (23.5 \u00b1 2.5 fmol\/mg membrane protein). RT-PCR analysis showed the presence of sst1, sst2A, and a predominant sst3 messenger RNA (mRNA) expression in the tumor tissue. Primary cultured tumor cells expressed sst3 mRNA only. In contrast to the normal thymus, SS mRNA was not expressed. By immunohistochemistry, the tumor cells highly expressed sst3 receptors, weakly expressed sst1 receptors, and showed no immunostaining for sst2A receptors. sst2A immunoreactivity was found in the stromal compartment of the tumor, particularly on the endothelium of small intratumoral blood vessels. In primary cultured tumor cells, both SS and octreotide (10 nmol\/L) significantly inhibited[ 3H]thymidine incorporation by 40.6% and 43.2%, respectively.<\/jats:p><jats:p>The following conclusions were reached. 1) As this tumor displayed a high immunoreactivity for sst3 and the cultured tumor cells expressed the sst3 mRNA only, this SSR may be the subtype involved in the inhibition of epithelial tumor cell proliferation by octreotide in vitro. 2) A loss of endogenous SS production in this thymoma might be implicated in the uncontrolled cell growth. 3) In this case, the sst3 may play a role in determining the uptake of[ 111In-DTPA-d-Phe1]octreotide by in vivo SS receptor scintigraphy.<\/jats:p>","DOI":"10.1210\/jcem.85.4.6547","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:05:32Z","timestamp":1389200732000},"page":"1719-1726","source":"Crossref","is-referenced-by-count":34,"title":["Somatostatin Receptor Subtypes in Human Thymoma and Inhibition of Cell Proliferation by Octreotide in Vitro"],"prefix":"10.1210","volume":"85","author":[{"given":"Diego","family":"Ferone","sequence":"first","affiliation":[{"name":"Departments of Internal Medicine III (D.F., M.P.v.H., P.M.v.K., D.M.M., E.G.R.L.-K., S.W.J.L., L.J.H.), 3015 AD Rotterdam, The Netherlands"},{"name":"Department of Molecular and Clinical Endocrinology and Oncology, Federico II University (D.F., A.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"van Hagen","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine III (D.F., M.P.v.H., P.M.v.K., D.M.M., E.G.R.L.-K., S.W.J.L., L.J.H.), 3015 AD Rotterdam, The Netherlands"},{"name":"Immunology (M.P.v.H.), 3015 AD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dik J.","family":"Kwekkeboom","sequence":"additional","affiliation":[{"name":"Nuclear Medicine (D.J.K.), Erasmus University, 3015 AD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"van Koetsveld","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine III (D.F., M.P.v.H., P.M.v.K., D.M.M., E.G.R.L.-K., S.W.J.L., L.J.H.), 3015 AD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Mooy","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine III (D.F., M.P.v.H., P.M.v.K., D.M.M., E.G.R.L.-K., S.W.J.L., L.J.H.), 3015 AD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elgin","family":"Lichtenauer-Kaligis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Scho\u0308nbrunn","sequence":"additional","affiliation":[{"name":"Department of Integrative Biology and Pharmacology, University of Texas (A.S.), Houston, Texas 77225"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Endocrinology and Oncology, Federico II University (D.F., A.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W. J.","family":"Lamberts","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine III (D.F., M.P.v.H., P.M.v.K., D.M.M., E.G.R.L.-K., S.W.J.L., L.J.H.), 3015 AD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo J.","family":"Hofland","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine III (D.F., M.P.v.H., P.M.v.K., D.M.M., E.G.R.L.-K., S.W.J.L., L.J.H.), 3015 AD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071620300766600_R1","first-page":"67","article-title":"Human intrathymic T cell differentiation.","volume":"2","author":"Haynes","year":"1990","journal-title":"Semin Immunol"},{"key":"2020071620300766600_R2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0167-5699(93)90248-J","article-title":"The thymic microenvironment.","volume":"14","author":"Boyd","year":"1993","journal-title":"Immunol Today"},{"key":"2020071620300766600_R3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0960-5428(97)00030-7","article-title":"Interdependence of the endocrine and immune systems.","volume":"6","author":"Dardenne","year":"1996","journal-title":"Adv Neuroimmunol"},{"key":"2020071620300766600_R4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2362.1994.tb00972.x","article-title":"Somatostatin and the immune and haematopoietic system; a review.","volume":"24","author":"Hagen","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"2020071620300766600_R5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0024-3205(95)02082-T","article-title":"The somatostatin receptor family.","volume":"57","author":"Patel","year":"1995","journal-title":"Life Sci"},{"key":"2020071620300766600_R6","first-page":"427","article-title":"Molecular biology of somatostatin receptors.","volume":"16","author":"Reisine","year":"1995","journal-title":"Endocr Rev"},{"key":"2020071620300766600_R7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/edrv-12-4-450","article-title":"The role of somatostatin and its analogs in the diagnosis and treatment of tumors.","volume":"12","author":"Lamberts","year":"1991","journal-title":"Endocr Rev"},{"key":"2020071620300766600_R8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0960-0760(90)90468-Z","article-title":"Somatostatin receptors in malignant tissues.","volume":"37","author":"Reubi","year":"1990","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071620300766600_R9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0002-9440(10)65564-2","article-title":"Immunohistochemical localization of somatostatin receptors sst2A in human tumors.","volume":"153","author":"Reubi","year":"1998","journal-title":"Am J Pathol"},{"key":"2020071620300766600_R10","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jcem.83.10.5314","article-title":"Immunohistochemical localization of somatostatin receptors sst2A in human pancreatic islets.","volume":"83","author":"Reubi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620300766600_R11","first-page":"2047","article-title":"Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies.","volume":"4","author":"Schulz So, Schulz St, Schmitt","year":"1998","journal-title":"Clin Cancer Res"},{"key":"2020071620300766600_R12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/jcem.84.2.5497","article-title":"Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors.","volume":"84","author":"Hofland","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620300766600_R13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diabetes.48.1.77","article-title":"Subtype-selective expression of the five somatostatin receptors (hSSTR1\u20135) in human pancreatic islet cells. A quantitative double-label immunohistochemical analysis.","volume":"48","author":"Kumar","year":"1999","journal-title":"Diabetes"},{"key":"2020071620300766600_R14"},{"key":"2020071620300766600_R15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1172\/JCI119225","article-title":"Somatostatin receptor subtype specificity in human fetal pituitary cultures Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.","volume":"99","author":"Shimon","year":"1997","journal-title":"J Clin Invest"},{"key":"2020071620300766600_R16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","article-title":"Somatostatin receptor scintigraphy with[ 111In-DTPA-d-Phe1]- and[ 123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.","volume":"20","author":"Krenning","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"2020071620300766600_R17","first-page":"2356","article-title":"Prediction of efficacy of octreotide therapy in patients with acromegaly.","volume":"81","author":"Colao","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620300766600_R18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/endo.140.1.6398","article-title":"In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells.","volume":"140","author":"Ferone","year":"1999","journal-title":"Endocrinology"},{"key":"2020071620300766600_R19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM199701233360405","article-title":"Successful treatment of a patient with thymoma and pure red-cell aplasia with octreotide and prednisone.","volume":"336","author":"Palmieri","year":"1997","journal-title":"N Engl J Med"},{"key":"2020071620300766600_R20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00003072-199901000-00006","article-title":"Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma.","volume":"24","author":"Lin","year":"1999","journal-title":"Clin Nucl Med"},{"key":"2020071620300766600_R21","first-page":"652","article-title":"Somatostatin receptor scintigraphy with indium-111-DTPA-d-Phe1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr3-octreotide.","volume":"33","author":"Krenning","year":"1992","journal-title":"J Nucl Med"},{"key":"2020071620300766600_R22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0026-895X(25)10566-X","article-title":"Development and use of a receptor antibody to characterize the interaction between somatostatin receptor subtype 1 and G proteins.","volume":"48","author":"Gu","year":"1995","journal-title":"Mol Pharmacol"},{"key":"2020071620300766600_R23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/mend.11.5.9926","article-title":"Coupling specificity between somatostatin receptor sst2A and G proteins: isolation of the receptor-G protein complex with a receptor antibody.","volume":"11","author":"Gu","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2020071620300766600_R24","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/1097-0142(19871201)60:11<2727::AID-CNCR2820601125>3.0.CO;2-D","article-title":"Thymoma. A clinicopathologic review.","volume":"60","author":"Lewis","year":"1987","journal-title":"Cancer"},{"key":"2020071620300766600_R25","first-page":"464","article-title":"Immunohistochemical evidence of active thymocyte proliferation in thymoma. Its possible role in the pathogenesis of autoimmune diseases.","volume":"128","author":"Chilosi","year":"1987","journal-title":"Am J Pathol"},{"key":"2020071620300766600_R26","first-page":"634","article-title":"In vivo detection of malignant thymic masses by[ 111In-DTPA-d-Phe1]-octreotide scintigraphy.","volume":"39","author":"Lastoria","year":"1998","journal-title":"J Nucl Med"},{"key":"2020071620300766600_R27","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood.V82.7.2143.2143","article-title":"In vitro and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue.","volume":"82","author":"Reubi","year":"1993","journal-title":"Blood"},{"key":"2020071620300766600_R28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0960-0760(92)90184-K","article-title":"Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications.","volume":"43","author":"Reubi","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071620300766600_R29","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1084\/jem.160.4.1054","article-title":"In vivo alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells.","volume":"160","year":"1984","journal-title":"J Exp Med"},{"key":"2020071620300766600_R30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0889-1591(87)90019-5","article-title":"Distribution of somatostatin receptors on murine spleen and Peyer\u2019s patch T and B lymphocytes.","volume":"1","author":"Scicchitano","year":"1987","journal-title":"Brain Behav Immunol"},{"key":"2020071620300766600_R31"},{"key":"2020071620300766600_R32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1182\/blood.V92.1.191.413k12_191_197","article-title":"Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs.","volume":"92","author":"Reubi","year":"1998","journal-title":"Blood"},{"key":"2020071620300766600_R33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/edrv-17-1-64","article-title":"Immune-neuro-endocrine interactions: facts and hypotheses.","volume":"17","author":"Besedovsky","year":"1996","journal-title":"Endocr Rev"},{"key":"2020071620300766600_R34","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1210\/endo.137.9.8756582","article-title":"Agonist-dependent regulation of cloned somatostatin receptor types 1\u20135 (hSSTR1\u20135): subtype selective internalization or upregulation.","volume":"137","author":"Hukovic","year":"1996","journal-title":"Endocrinology"},{"key":"2020071620300766600_R35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/jcp.43.10.829","article-title":"Cells immunoreactive for neuropeptide in human thymoma.","volume":"43","author":"Lauriola","year":"1990","journal-title":"J Clin Pathol"},{"key":"2020071620300766600_R36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1006\/bbrc.1995.1517","article-title":"Cell cycle dependent induction of apoptosis by somatostatin analog SMS 201\u2013995 in AtT-20 mouse pituitary cell.","volume":"209","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071620300766600_R37","first-page":"1688","article-title":"Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.","volume":"10","author":"Sharma","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2020071620300766600_R38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ajcp\/104.4.375","article-title":"p53 protein expression and p53 gene mutation in thymic epithelial tumours.","volume":"104","author":"Tateyama","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"2020071620300766600_R39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s004280050064","article-title":"p53 alterations in thymic epithelial tumours.","volume":"431","author":"Weirich","year":"1997","journal-title":"Virchows Arch"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/4\/1719\/10403628\/jcem1719.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/4\/1719\/10403628\/jcem1719.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:58:18Z","timestamp":1746100698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/85\/4\/1719\/2856202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.85.4.6547","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4,1]]}}}